Loading…

Chemical traits of cerebral amyloid angiopathy in familial British‐, Danish‐, and non‐Alzheimer ʼs dementias

Familial British dementia (FBD) and familial Danish dementia (FDD) are autosomal dominant forms of dementia caused by mutations in the integral membrane protein 2B ( ITM2B , also known as BRI2 ) gene. Secretase processing of mutant BRI2 leads to secretion and deposition of BRI2‐derived amyloidogenic...

Full description

Saved in:
Bibliographic Details
Published in:Journal of neurochemistry 2022-11, Vol.163 (3), p.233-246
Main Authors: Michno, Wojciech, Koutarapu, Srinivas, Camacho, Rafael, Toomey, Christina, Stringer, Katie, Minta, Karolina, Ge, Junyue, Jha, Durga, Fernandez‐Rodriguez, Julia, Brinkmalm, Gunnar, Zetterberg, Henrik, Blennow, Kaj, Ryan, Natalie S., Lashley, Tammaryn, Hanrieder, Jörg
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c197t-c075e46b69b32b300589040218bf68d0eef54dcf8c85f5d4d0afcffcc99fbbbb3
cites cdi_FETCH-LOGICAL-c197t-c075e46b69b32b300589040218bf68d0eef54dcf8c85f5d4d0afcffcc99fbbbb3
container_end_page 246
container_issue 3
container_start_page 233
container_title Journal of neurochemistry
container_volume 163
creator Michno, Wojciech
Koutarapu, Srinivas
Camacho, Rafael
Toomey, Christina
Stringer, Katie
Minta, Karolina
Ge, Junyue
Jha, Durga
Fernandez‐Rodriguez, Julia
Brinkmalm, Gunnar
Zetterberg, Henrik
Blennow, Kaj
Ryan, Natalie S.
Lashley, Tammaryn
Hanrieder, Jörg
description Familial British dementia (FBD) and familial Danish dementia (FDD) are autosomal dominant forms of dementia caused by mutations in the integral membrane protein 2B ( ITM2B , also known as BRI2 ) gene. Secretase processing of mutant BRI2 leads to secretion and deposition of BRI2‐derived amyloidogenic peptides, ABri and ADan that resemble APP/β‐amyloid (Aβ) pathology, which is characteristic of Alzheimer's disease (AD). Amyloid pathology in FBD/FDD manifests itself predominantly in the microvasculature by ABri/ADan containing cerebral amyloid angiopathy (CAA). While ABri and ADan peptide sequences differ only in a few C‐terminal amino acids, CAA in FDD is characterized by co‐aggregation of ADan with Aβ, while in contrast no Aβ deposition is observed in FBD. The fact that FDD patients display an earlier and more severe disease onset than FBD suggests a potential role of ADan and Aβ co‐aggregation that promotes a more rapid disease progression in FDD compared to FBD. It is therefore critical to delineate the chemical signatures of amyloid aggregation in these two vascular dementias. This in turn will increase the knowledge on the pathophysiology of these diseases and the pathogenic role of heterogenous amyloid peptide interactions and deposition, respectively. Herein, we used matrix‐assisted laser desorption/ionization mass spectrometry imaging (MALDI‐MSI) in combination with hyperspectral, confocal microscopy based on luminescent conjugated oligothiophene probes (LCO) to delineate the structural traits and associated amyloid peptide patterns of single CAA in postmortem brain tissue of patients with FBD, FDD as well as sporadic CAA without AD (CAA+) that show pronounced CAA without parenchymal plaques. The results show that CAA in both FBD and FDD consist of N‐terminally truncated‐ and pyroglutamate‐modified amyloid peptide species (ADan and ABri), but that ADan peptides in FDD are also extensively C‐terminally truncated as compared to ABri in FBD, which contributes to hydrophobicity of ADan species. Further, CAA in FDD showed co‐deposition with Aβ x‐42 and Aβ x‐40 species. CAA+ vessels were structurally more mature than FDD/FBD CAA and contained significant amounts of pyroglutamated Aβ. When compared with FDD, Aβ in CAA+ showed more C‐terminal and less N‐terminally truncations. In FDD, ADan showed spatial co‐localization with Aβ3pE‐40 and Aβ3‐40 but not with Aβx‐42 species. This suggests an increased aggregation propensity of Aβ in FDD that promotes co‐aggreg
doi_str_mv 10.1111/jnc.15694
format article
fullrecord <record><control><sourceid>swepub_cross</sourceid><recordid>TN_cdi_swepub_primary_oai_gup_ub_gu_se_321291</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>oai_gup_ub_gu_se_321291</sourcerecordid><originalsourceid>FETCH-LOGICAL-c197t-c075e46b69b32b300589040218bf68d0eef54dcf8c85f5d4d0afcffcc99fbbbb3</originalsourceid><addsrcrecordid>eNo9kE1OwzAQhS0EEqWw4AbeIpFiO04aL0v4lSqxgbXl38ZV4kR2KlRWHIEDcQKOwUkwFHibeXrzZhYfAKcYzXDSxdqrGS5KRvfABNM5zigu2D6YIERIliNKDsFRjGuEcElLPAGxbkznlGjhGIQbI-wtVCYYGVIkum3bOw2FX7l-EGOzhc5DKzrXurS-DG50sfl8fTuHV8L_WeE19L1PftG-NMZ1JsCP9wi16YwfnYjH4MCKNpqT3zkFTzfXj_Vdtny4va8Xy0xhNh8zheaFoaUsmcyJzBEqKoYoIriStqw0MsYWVCtbqaqwhaYaCausVYoxK5PyKch2f-OzGTaSD8F1Imx5LxxfbQaeotWGR8NzggnDqX-266vQxxiM_b_AiH_T5Yku_6GbfwEb_HOr</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Chemical traits of cerebral amyloid angiopathy in familial British‐, Danish‐, and non‐Alzheimer ʼs dementias</title><source>Wiley-Blackwell Read &amp; Publish Collection</source><source>Free Full-Text Journals in Chemistry</source><creator>Michno, Wojciech ; Koutarapu, Srinivas ; Camacho, Rafael ; Toomey, Christina ; Stringer, Katie ; Minta, Karolina ; Ge, Junyue ; Jha, Durga ; Fernandez‐Rodriguez, Julia ; Brinkmalm, Gunnar ; Zetterberg, Henrik ; Blennow, Kaj ; Ryan, Natalie S. ; Lashley, Tammaryn ; Hanrieder, Jörg</creator><creatorcontrib>Michno, Wojciech ; Koutarapu, Srinivas ; Camacho, Rafael ; Toomey, Christina ; Stringer, Katie ; Minta, Karolina ; Ge, Junyue ; Jha, Durga ; Fernandez‐Rodriguez, Julia ; Brinkmalm, Gunnar ; Zetterberg, Henrik ; Blennow, Kaj ; Ryan, Natalie S. ; Lashley, Tammaryn ; Hanrieder, Jörg</creatorcontrib><description>Familial British dementia (FBD) and familial Danish dementia (FDD) are autosomal dominant forms of dementia caused by mutations in the integral membrane protein 2B ( ITM2B , also known as BRI2 ) gene. Secretase processing of mutant BRI2 leads to secretion and deposition of BRI2‐derived amyloidogenic peptides, ABri and ADan that resemble APP/β‐amyloid (Aβ) pathology, which is characteristic of Alzheimer's disease (AD). Amyloid pathology in FBD/FDD manifests itself predominantly in the microvasculature by ABri/ADan containing cerebral amyloid angiopathy (CAA). While ABri and ADan peptide sequences differ only in a few C‐terminal amino acids, CAA in FDD is characterized by co‐aggregation of ADan with Aβ, while in contrast no Aβ deposition is observed in FBD. The fact that FDD patients display an earlier and more severe disease onset than FBD suggests a potential role of ADan and Aβ co‐aggregation that promotes a more rapid disease progression in FDD compared to FBD. It is therefore critical to delineate the chemical signatures of amyloid aggregation in these two vascular dementias. This in turn will increase the knowledge on the pathophysiology of these diseases and the pathogenic role of heterogenous amyloid peptide interactions and deposition, respectively. Herein, we used matrix‐assisted laser desorption/ionization mass spectrometry imaging (MALDI‐MSI) in combination with hyperspectral, confocal microscopy based on luminescent conjugated oligothiophene probes (LCO) to delineate the structural traits and associated amyloid peptide patterns of single CAA in postmortem brain tissue of patients with FBD, FDD as well as sporadic CAA without AD (CAA+) that show pronounced CAA without parenchymal plaques. The results show that CAA in both FBD and FDD consist of N‐terminally truncated‐ and pyroglutamate‐modified amyloid peptide species (ADan and ABri), but that ADan peptides in FDD are also extensively C‐terminally truncated as compared to ABri in FBD, which contributes to hydrophobicity of ADan species. Further, CAA in FDD showed co‐deposition with Aβ x‐42 and Aβ x‐40 species. CAA+ vessels were structurally more mature than FDD/FBD CAA and contained significant amounts of pyroglutamated Aβ. When compared with FDD, Aβ in CAA+ showed more C‐terminal and less N‐terminally truncations. In FDD, ADan showed spatial co‐localization with Aβ3pE‐40 and Aβ3‐40 but not with Aβx‐42 species. This suggests an increased aggregation propensity of Aβ in FDD that promotes co‐aggregation of both Aβ and ADan. Further, CAA maturity appears to be mainly governed by Aβ content based on the significantly higher 500/580 patterns observed in CAA+ than in FDD and FBD, respectively. Together this is the first study of its kind on comprehensive delineation of Bri2 and APP‐derived amyloid peptides in single vascular plaques in both FDD/FBD and sporadic CAA that provides new insight in non‐AD‐related vascular amyloid pathology. image Cover Image for this issue: https://doi.org/10.1111/jnc.15424</description><identifier>ISSN: 0022-3042</identifier><identifier>EISSN: 1471-4159</identifier><identifier>DOI: 10.1111/jnc.15694</identifier><language>eng</language><subject>a-beta ; ABri ; ADan ; Alzheimer's disease (AD) ; association ; Biochemistry &amp; Molecular Biology ; cerebral amyloid angiopathy (CAA) ; deposition ; disease ; familial British dementia (FBD) ; familial Danish dementia (FDD) ; guidelines ; human brain ; interstitial fluid ; Neurosciences ; Neurosciences &amp; Neurology ; Neurovetenskaper ; peptide ; polymorphism ; relevance</subject><ispartof>Journal of neurochemistry, 2022-11, Vol.163 (3), p.233-246</ispartof><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c197t-c075e46b69b32b300589040218bf68d0eef54dcf8c85f5d4d0afcffcc99fbbbb3</citedby><cites>FETCH-LOGICAL-c197t-c075e46b69b32b300589040218bf68d0eef54dcf8c85f5d4d0afcffcc99fbbbb3</cites><orcidid>0000-0003-2325-6407 ; 0000-0001-6059-198X ; 0000-0003-3930-4354 ; 0000-0002-3096-3604</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>230,314,780,784,885,27924,27925</link.rule.ids><backlink>$$Uhttps://gup.ub.gu.se/publication/321291$$DView record from Swedish Publication Index$$Hfree_for_read</backlink></links><search><creatorcontrib>Michno, Wojciech</creatorcontrib><creatorcontrib>Koutarapu, Srinivas</creatorcontrib><creatorcontrib>Camacho, Rafael</creatorcontrib><creatorcontrib>Toomey, Christina</creatorcontrib><creatorcontrib>Stringer, Katie</creatorcontrib><creatorcontrib>Minta, Karolina</creatorcontrib><creatorcontrib>Ge, Junyue</creatorcontrib><creatorcontrib>Jha, Durga</creatorcontrib><creatorcontrib>Fernandez‐Rodriguez, Julia</creatorcontrib><creatorcontrib>Brinkmalm, Gunnar</creatorcontrib><creatorcontrib>Zetterberg, Henrik</creatorcontrib><creatorcontrib>Blennow, Kaj</creatorcontrib><creatorcontrib>Ryan, Natalie S.</creatorcontrib><creatorcontrib>Lashley, Tammaryn</creatorcontrib><creatorcontrib>Hanrieder, Jörg</creatorcontrib><title>Chemical traits of cerebral amyloid angiopathy in familial British‐, Danish‐, and non‐Alzheimer ʼs dementias</title><title>Journal of neurochemistry</title><description>Familial British dementia (FBD) and familial Danish dementia (FDD) are autosomal dominant forms of dementia caused by mutations in the integral membrane protein 2B ( ITM2B , also known as BRI2 ) gene. Secretase processing of mutant BRI2 leads to secretion and deposition of BRI2‐derived amyloidogenic peptides, ABri and ADan that resemble APP/β‐amyloid (Aβ) pathology, which is characteristic of Alzheimer's disease (AD). Amyloid pathology in FBD/FDD manifests itself predominantly in the microvasculature by ABri/ADan containing cerebral amyloid angiopathy (CAA). While ABri and ADan peptide sequences differ only in a few C‐terminal amino acids, CAA in FDD is characterized by co‐aggregation of ADan with Aβ, while in contrast no Aβ deposition is observed in FBD. The fact that FDD patients display an earlier and more severe disease onset than FBD suggests a potential role of ADan and Aβ co‐aggregation that promotes a more rapid disease progression in FDD compared to FBD. It is therefore critical to delineate the chemical signatures of amyloid aggregation in these two vascular dementias. This in turn will increase the knowledge on the pathophysiology of these diseases and the pathogenic role of heterogenous amyloid peptide interactions and deposition, respectively. Herein, we used matrix‐assisted laser desorption/ionization mass spectrometry imaging (MALDI‐MSI) in combination with hyperspectral, confocal microscopy based on luminescent conjugated oligothiophene probes (LCO) to delineate the structural traits and associated amyloid peptide patterns of single CAA in postmortem brain tissue of patients with FBD, FDD as well as sporadic CAA without AD (CAA+) that show pronounced CAA without parenchymal plaques. The results show that CAA in both FBD and FDD consist of N‐terminally truncated‐ and pyroglutamate‐modified amyloid peptide species (ADan and ABri), but that ADan peptides in FDD are also extensively C‐terminally truncated as compared to ABri in FBD, which contributes to hydrophobicity of ADan species. Further, CAA in FDD showed co‐deposition with Aβ x‐42 and Aβ x‐40 species. CAA+ vessels were structurally more mature than FDD/FBD CAA and contained significant amounts of pyroglutamated Aβ. When compared with FDD, Aβ in CAA+ showed more C‐terminal and less N‐terminally truncations. In FDD, ADan showed spatial co‐localization with Aβ3pE‐40 and Aβ3‐40 but not with Aβx‐42 species. This suggests an increased aggregation propensity of Aβ in FDD that promotes co‐aggregation of both Aβ and ADan. Further, CAA maturity appears to be mainly governed by Aβ content based on the significantly higher 500/580 patterns observed in CAA+ than in FDD and FBD, respectively. Together this is the first study of its kind on comprehensive delineation of Bri2 and APP‐derived amyloid peptides in single vascular plaques in both FDD/FBD and sporadic CAA that provides new insight in non‐AD‐related vascular amyloid pathology. image Cover Image for this issue: https://doi.org/10.1111/jnc.15424</description><subject>a-beta</subject><subject>ABri</subject><subject>ADan</subject><subject>Alzheimer's disease (AD)</subject><subject>association</subject><subject>Biochemistry &amp; Molecular Biology</subject><subject>cerebral amyloid angiopathy (CAA)</subject><subject>deposition</subject><subject>disease</subject><subject>familial British dementia (FBD)</subject><subject>familial Danish dementia (FDD)</subject><subject>guidelines</subject><subject>human brain</subject><subject>interstitial fluid</subject><subject>Neurosciences</subject><subject>Neurosciences &amp; Neurology</subject><subject>Neurovetenskaper</subject><subject>peptide</subject><subject>polymorphism</subject><subject>relevance</subject><issn>0022-3042</issn><issn>1471-4159</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2022</creationdate><recordtype>article</recordtype><recordid>eNo9kE1OwzAQhS0EEqWw4AbeIpFiO04aL0v4lSqxgbXl38ZV4kR2KlRWHIEDcQKOwUkwFHibeXrzZhYfAKcYzXDSxdqrGS5KRvfABNM5zigu2D6YIERIliNKDsFRjGuEcElLPAGxbkznlGjhGIQbI-wtVCYYGVIkum3bOw2FX7l-EGOzhc5DKzrXurS-DG50sfl8fTuHV8L_WeE19L1PftG-NMZ1JsCP9wi16YwfnYjH4MCKNpqT3zkFTzfXj_Vdtny4va8Xy0xhNh8zheaFoaUsmcyJzBEqKoYoIriStqw0MsYWVCtbqaqwhaYaCausVYoxK5PyKch2f-OzGTaSD8F1Imx5LxxfbQaeotWGR8NzggnDqX-266vQxxiM_b_AiH_T5Yku_6GbfwEb_HOr</recordid><startdate>20221101</startdate><enddate>20221101</enddate><creator>Michno, Wojciech</creator><creator>Koutarapu, Srinivas</creator><creator>Camacho, Rafael</creator><creator>Toomey, Christina</creator><creator>Stringer, Katie</creator><creator>Minta, Karolina</creator><creator>Ge, Junyue</creator><creator>Jha, Durga</creator><creator>Fernandez‐Rodriguez, Julia</creator><creator>Brinkmalm, Gunnar</creator><creator>Zetterberg, Henrik</creator><creator>Blennow, Kaj</creator><creator>Ryan, Natalie S.</creator><creator>Lashley, Tammaryn</creator><creator>Hanrieder, Jörg</creator><scope>AAYXX</scope><scope>CITATION</scope><scope>ADTPV</scope><scope>AOWAS</scope><scope>F1U</scope><orcidid>https://orcid.org/0000-0003-2325-6407</orcidid><orcidid>https://orcid.org/0000-0001-6059-198X</orcidid><orcidid>https://orcid.org/0000-0003-3930-4354</orcidid><orcidid>https://orcid.org/0000-0002-3096-3604</orcidid></search><sort><creationdate>20221101</creationdate><title>Chemical traits of cerebral amyloid angiopathy in familial British‐, Danish‐, and non‐Alzheimer ʼs dementias</title><author>Michno, Wojciech ; Koutarapu, Srinivas ; Camacho, Rafael ; Toomey, Christina ; Stringer, Katie ; Minta, Karolina ; Ge, Junyue ; Jha, Durga ; Fernandez‐Rodriguez, Julia ; Brinkmalm, Gunnar ; Zetterberg, Henrik ; Blennow, Kaj ; Ryan, Natalie S. ; Lashley, Tammaryn ; Hanrieder, Jörg</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c197t-c075e46b69b32b300589040218bf68d0eef54dcf8c85f5d4d0afcffcc99fbbbb3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2022</creationdate><topic>a-beta</topic><topic>ABri</topic><topic>ADan</topic><topic>Alzheimer's disease (AD)</topic><topic>association</topic><topic>Biochemistry &amp; Molecular Biology</topic><topic>cerebral amyloid angiopathy (CAA)</topic><topic>deposition</topic><topic>disease</topic><topic>familial British dementia (FBD)</topic><topic>familial Danish dementia (FDD)</topic><topic>guidelines</topic><topic>human brain</topic><topic>interstitial fluid</topic><topic>Neurosciences</topic><topic>Neurosciences &amp; Neurology</topic><topic>Neurovetenskaper</topic><topic>peptide</topic><topic>polymorphism</topic><topic>relevance</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Michno, Wojciech</creatorcontrib><creatorcontrib>Koutarapu, Srinivas</creatorcontrib><creatorcontrib>Camacho, Rafael</creatorcontrib><creatorcontrib>Toomey, Christina</creatorcontrib><creatorcontrib>Stringer, Katie</creatorcontrib><creatorcontrib>Minta, Karolina</creatorcontrib><creatorcontrib>Ge, Junyue</creatorcontrib><creatorcontrib>Jha, Durga</creatorcontrib><creatorcontrib>Fernandez‐Rodriguez, Julia</creatorcontrib><creatorcontrib>Brinkmalm, Gunnar</creatorcontrib><creatorcontrib>Zetterberg, Henrik</creatorcontrib><creatorcontrib>Blennow, Kaj</creatorcontrib><creatorcontrib>Ryan, Natalie S.</creatorcontrib><creatorcontrib>Lashley, Tammaryn</creatorcontrib><creatorcontrib>Hanrieder, Jörg</creatorcontrib><collection>CrossRef</collection><collection>SwePub</collection><collection>SwePub Articles</collection><collection>SWEPUB Göteborgs universitet</collection><jtitle>Journal of neurochemistry</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Michno, Wojciech</au><au>Koutarapu, Srinivas</au><au>Camacho, Rafael</au><au>Toomey, Christina</au><au>Stringer, Katie</au><au>Minta, Karolina</au><au>Ge, Junyue</au><au>Jha, Durga</au><au>Fernandez‐Rodriguez, Julia</au><au>Brinkmalm, Gunnar</au><au>Zetterberg, Henrik</au><au>Blennow, Kaj</au><au>Ryan, Natalie S.</au><au>Lashley, Tammaryn</au><au>Hanrieder, Jörg</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Chemical traits of cerebral amyloid angiopathy in familial British‐, Danish‐, and non‐Alzheimer ʼs dementias</atitle><jtitle>Journal of neurochemistry</jtitle><date>2022-11-01</date><risdate>2022</risdate><volume>163</volume><issue>3</issue><spage>233</spage><epage>246</epage><pages>233-246</pages><issn>0022-3042</issn><eissn>1471-4159</eissn><abstract>Familial British dementia (FBD) and familial Danish dementia (FDD) are autosomal dominant forms of dementia caused by mutations in the integral membrane protein 2B ( ITM2B , also known as BRI2 ) gene. Secretase processing of mutant BRI2 leads to secretion and deposition of BRI2‐derived amyloidogenic peptides, ABri and ADan that resemble APP/β‐amyloid (Aβ) pathology, which is characteristic of Alzheimer's disease (AD). Amyloid pathology in FBD/FDD manifests itself predominantly in the microvasculature by ABri/ADan containing cerebral amyloid angiopathy (CAA). While ABri and ADan peptide sequences differ only in a few C‐terminal amino acids, CAA in FDD is characterized by co‐aggregation of ADan with Aβ, while in contrast no Aβ deposition is observed in FBD. The fact that FDD patients display an earlier and more severe disease onset than FBD suggests a potential role of ADan and Aβ co‐aggregation that promotes a more rapid disease progression in FDD compared to FBD. It is therefore critical to delineate the chemical signatures of amyloid aggregation in these two vascular dementias. This in turn will increase the knowledge on the pathophysiology of these diseases and the pathogenic role of heterogenous amyloid peptide interactions and deposition, respectively. Herein, we used matrix‐assisted laser desorption/ionization mass spectrometry imaging (MALDI‐MSI) in combination with hyperspectral, confocal microscopy based on luminescent conjugated oligothiophene probes (LCO) to delineate the structural traits and associated amyloid peptide patterns of single CAA in postmortem brain tissue of patients with FBD, FDD as well as sporadic CAA without AD (CAA+) that show pronounced CAA without parenchymal plaques. The results show that CAA in both FBD and FDD consist of N‐terminally truncated‐ and pyroglutamate‐modified amyloid peptide species (ADan and ABri), but that ADan peptides in FDD are also extensively C‐terminally truncated as compared to ABri in FBD, which contributes to hydrophobicity of ADan species. Further, CAA in FDD showed co‐deposition with Aβ x‐42 and Aβ x‐40 species. CAA+ vessels were structurally more mature than FDD/FBD CAA and contained significant amounts of pyroglutamated Aβ. When compared with FDD, Aβ in CAA+ showed more C‐terminal and less N‐terminally truncations. In FDD, ADan showed spatial co‐localization with Aβ3pE‐40 and Aβ3‐40 but not with Aβx‐42 species. This suggests an increased aggregation propensity of Aβ in FDD that promotes co‐aggregation of both Aβ and ADan. Further, CAA maturity appears to be mainly governed by Aβ content based on the significantly higher 500/580 patterns observed in CAA+ than in FDD and FBD, respectively. Together this is the first study of its kind on comprehensive delineation of Bri2 and APP‐derived amyloid peptides in single vascular plaques in both FDD/FBD and sporadic CAA that provides new insight in non‐AD‐related vascular amyloid pathology. image Cover Image for this issue: https://doi.org/10.1111/jnc.15424</abstract><doi>10.1111/jnc.15694</doi><tpages>14</tpages><orcidid>https://orcid.org/0000-0003-2325-6407</orcidid><orcidid>https://orcid.org/0000-0001-6059-198X</orcidid><orcidid>https://orcid.org/0000-0003-3930-4354</orcidid><orcidid>https://orcid.org/0000-0002-3096-3604</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0022-3042
ispartof Journal of neurochemistry, 2022-11, Vol.163 (3), p.233-246
issn 0022-3042
1471-4159
language eng
recordid cdi_swepub_primary_oai_gup_ub_gu_se_321291
source Wiley-Blackwell Read & Publish Collection; Free Full-Text Journals in Chemistry
subjects a-beta
ABri
ADan
Alzheimer's disease (AD)
association
Biochemistry & Molecular Biology
cerebral amyloid angiopathy (CAA)
deposition
disease
familial British dementia (FBD)
familial Danish dementia (FDD)
guidelines
human brain
interstitial fluid
Neurosciences
Neurosciences & Neurology
Neurovetenskaper
peptide
polymorphism
relevance
title Chemical traits of cerebral amyloid angiopathy in familial British‐, Danish‐, and non‐Alzheimer ʼs dementias
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-25T02%3A48%3A49IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-swepub_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Chemical%20traits%20of%20cerebral%20amyloid%20angiopathy%20in%20familial%20British%E2%80%90,%20Danish%E2%80%90,%20and%20non%E2%80%90Alzheimer%20%CA%BCs%20dementias&rft.jtitle=Journal%20of%20neurochemistry&rft.au=Michno,%20Wojciech&rft.date=2022-11-01&rft.volume=163&rft.issue=3&rft.spage=233&rft.epage=246&rft.pages=233-246&rft.issn=0022-3042&rft.eissn=1471-4159&rft_id=info:doi/10.1111/jnc.15694&rft_dat=%3Cswepub_cross%3Eoai_gup_ub_gu_se_321291%3C/swepub_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c197t-c075e46b69b32b300589040218bf68d0eef54dcf8c85f5d4d0afcffcc99fbbbb3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true